share_log

Earnings Call Summary | Moolec Science(MLEC.US) Q3 2024 Earnings Conference

Futu News ·  May 31 11:44  · Conference Call

The following is a summary of the Moolec Science SA (MLEC) Q3 2024 Earnings Call Transcript:

Financial Performance:

  • Revenue increased year-over-year from nil to approximately $1.3 million.

  • Gross margin stood at 18%.

  • Operational cash flow was approximately $2.7 million with a decrease in cash utilization year-over-year.

  • Moolec's cash position strengthened by approximately $2 million due to additional funding.

Business Progress:

  • Achieved USDA-APHIS regulatory approval for Piggy Sooy.

  • Initiated field trials for Piggy Sooy in three different U.S. locations.

  • GLASO is in pre-commercial stages with intended market penetration in 2025.

  • Two U.S. patents granted for SPC2 technology extending protection till 2041.

Opportunities:

  • Moolec's Piggy Sooy provides a sustainable alternative to traditional livestock farming, reducing water and CO2 emissions.

  • Expected commercial adoption and scaling of Piggy Sooy and GLASO in the forthcoming years.

Risks:

  • Dependence on the success and commercial acceptance of Piggy Sooy and other products still in pre-commercial or early commercial stages.

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment